Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) Stock Competitors & Peer Comparison
See (2395.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2395.T | ¥1,448.00 | +2.04% | 58.9B | 12.64 | ¥111.84 | +3.11% |
| 4544.T | ¥3,238.00 | +0.65% | 181.3B | 65.69 | ¥48.58 | +3.52% |
| 4694.T | ¥4,080.00 | +0.49% | 151.6B | 22.20 | ¥182.21 | +2.67% |
| 2309.T | ¥2,644.00 | +0.46% | 44.6B | 8.48 | ¥311.89 | N/A |
| 4671.T | ¥2,635.00 | +1.62% | 26.1B | 14.01 | ¥186.23 | +4.30% |
| 2397.T | ¥1,092.00 | +0.18% | 7.4B | -59.64 | -¥18.31 | N/A |
| 3386.T | ¥1,288.00 | +2.88% | 7.2B | 21.29 | ¥59.22 | +3.56% |
| 9776.T | ¥1,952.00 | -0.41% | 6.1B | 0.00 | ¥27,381,640.00 | +1.18% |
| 7707.T | ¥218.00 | +4.31% | 5.6B | -156.92 | -¥1.30 | N/A |
| 6090.T | ¥682.00 | -2.71% | 3.8B | 19.17 | ¥35.63 | +2.20% |
Stock Comparison
2395.T vs 4544.T Comparison April 2026
2395.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2395.T stands at 58.9B. In comparison, 4544.T has a market cap of 181.3B. Regarding current trading prices, 2395.T is priced at ¥1,448.00, while 4544.T trades at ¥3,238.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2395.T currently has a P/E ratio of 12.64, whereas 4544.T's P/E ratio is 65.69. In terms of profitability, 2395.T's ROE is +0.10%, compared to 4544.T's ROE of +0.04%. Regarding short-term risk, 2395.T is more volatile compared to 4544.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2395.T.Check 4544.T's competition here